| Dr Robert Obie Robinson, MD | |
|
5995 Bicentennial Ln, Beaumont, TX 77706-2504 | |
| (409) 898-2760 | |
| Not Available |
| Full Name | Dr Robert Obie Robinson |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 56 Years |
| Location | 5995 Bicentennial Ln, Beaumont, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386756989 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | D5179 (Texas) | Primary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | D5179 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kotel Atx | 9537578810 | 16 |
News Archive
A recent study among 3- to 7-year-old children showed that children's motor skills benefitted if a child was older and participated in organized sports.
BioNano Genomics announced today a $10 million financing to support the ongoing development and commercialization of the IrysTM System for human genome analysis. Current investors, Battelle Ventures, Domain Associates, Gund Investment Corporation, participated in the financing.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
Pharmaxis, Inc., a wholly owned subsidiary of Pharmaxis Ltd , an emerging respiratory specialty pharmaceutical company, announced today that it has filed a New Drug Application (NDA), electronically, with the U.S. Food and Drug Administration (FDA) for Aridol (mannitol bronchial challenge test).
Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval for LATITUDE 6.0, a software upgrade to the Company's LATITUDE® Patient Management system. The LATITUDE system enables physicians to remotely monitor patients with implantable cardiac devices. The upgrade provides enhanced functionality, including the ability to view an expanded history of a patient's remote follow-up data.
› Verified 6 days ago
| Entity Name | Winnie Community Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295781227 PECOS PAC ID: 3375440894 Enrollment ID: O20031218000349 |
News Archive
A recent study among 3- to 7-year-old children showed that children's motor skills benefitted if a child was older and participated in organized sports.
BioNano Genomics announced today a $10 million financing to support the ongoing development and commercialization of the IrysTM System for human genome analysis. Current investors, Battelle Ventures, Domain Associates, Gund Investment Corporation, participated in the financing.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
Pharmaxis, Inc., a wholly owned subsidiary of Pharmaxis Ltd , an emerging respiratory specialty pharmaceutical company, announced today that it has filed a New Drug Application (NDA), electronically, with the U.S. Food and Drug Administration (FDA) for Aridol (mannitol bronchial challenge test).
Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval for LATITUDE 6.0, a software upgrade to the Company's LATITUDE® Patient Management system. The LATITUDE system enables physicians to remotely monitor patients with implantable cardiac devices. The upgrade provides enhanced functionality, including the ability to view an expanded history of a patient's remote follow-up data.
› Verified 6 days ago
| Entity Name | Kotel Atx |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568055192 PECOS PAC ID: 9537578810 Enrollment ID: O20210518000994 |
News Archive
A recent study among 3- to 7-year-old children showed that children's motor skills benefitted if a child was older and participated in organized sports.
BioNano Genomics announced today a $10 million financing to support the ongoing development and commercialization of the IrysTM System for human genome analysis. Current investors, Battelle Ventures, Domain Associates, Gund Investment Corporation, participated in the financing.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
Pharmaxis, Inc., a wholly owned subsidiary of Pharmaxis Ltd , an emerging respiratory specialty pharmaceutical company, announced today that it has filed a New Drug Application (NDA), electronically, with the U.S. Food and Drug Administration (FDA) for Aridol (mannitol bronchial challenge test).
Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval for LATITUDE 6.0, a software upgrade to the Company's LATITUDE® Patient Management system. The LATITUDE system enables physicians to remotely monitor patients with implantable cardiac devices. The upgrade provides enhanced functionality, including the ability to view an expanded history of a patient's remote follow-up data.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Obie Robinson, MD 5995 Bicentennial Ln, Beaumont, TX 77706-2504 Ph: (409) 898-2760 | Dr Robert Obie Robinson, MD 5995 Bicentennial Ln, Beaumont, TX 77706-2504 Ph: (409) 898-2760 |
News Archive
A recent study among 3- to 7-year-old children showed that children's motor skills benefitted if a child was older and participated in organized sports.
BioNano Genomics announced today a $10 million financing to support the ongoing development and commercialization of the IrysTM System for human genome analysis. Current investors, Battelle Ventures, Domain Associates, Gund Investment Corporation, participated in the financing.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
Pharmaxis, Inc., a wholly owned subsidiary of Pharmaxis Ltd , an emerging respiratory specialty pharmaceutical company, announced today that it has filed a New Drug Application (NDA), electronically, with the U.S. Food and Drug Administration (FDA) for Aridol (mannitol bronchial challenge test).
Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval for LATITUDE 6.0, a software upgrade to the Company's LATITUDE® Patient Management system. The LATITUDE system enables physicians to remotely monitor patients with implantable cardiac devices. The upgrade provides enhanced functionality, including the ability to view an expanded history of a patient's remote follow-up data.
› Verified 6 days ago
Dr. Edward Brown Gripon, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3560 Delaware St, #502, Beaumont, TX 77706 Phone: 409-899-4472 Fax: 409-899-9795 | |
George E Groves, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3455 Stagg Dr, Beaumont, TX 77701 Phone: 832-548-5000 | |
Dr. Lauren James, D.O. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 2750 S 8th St, Beaumont, TX 77701 Phone: 409-839-1000 | |
Leonora K Petty, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2750 S 8th St, Beaumont, TX 77701 Phone: 409-839-1000 | |
Rosa Cristina Gonzalez, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3560 Delaware St Ste 109, Beaumont, TX 77706 Phone: 409-892-9347 Fax: 409-892-8803 | |
Mark Bradley Morman, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2750 S 8th St Bldg A, Beaumont, TX 77701 Phone: 409-839-1032 Fax: 409-839-1069 | |
Dr. Raul D Isern Jr., M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3438 Fannin St, Bldg. 3, Beaumont, TX 77701 Phone: 409-835-2677 Fax: 409-835-0464 |